ArticleERJ open research2026
Predicting clinical exacerbations using respiratory oscillometry during home telemonitoring of patients taking medium-/high-dose asthma treatment.
Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rationale: Strategies for asthma management need better tools to identify risk of exacerbations. In this prospective observational study, we investigated day-to-day variability of lung mechanics, measured using home telemonitored oscillometry, by examining relationships between current symptom control and future risk of exacerbation in asthma patients taking medium-/high-dose treatment, regardless of their level of asthma control. Methods: Participants underwent ≥24 weeks of telemonitoring during stable or stepped-down treatment, with once-daily self-recording of symptoms, and oscillometry (Resmon Pro Diary, Restech Srl, Milan, Italy). The 5-item Asthma Control Questionnaire and exacerbations were captured Results: Data from 30 participants were analysed (19 female; mean±sd age 59±13 years, body mass index 30.1±6.6 kg·m Conclusion: This proof-of-concept study shows that daily telemonitoring of oscillometry is useful for assessing current symptom control and future risk of exacerbations in asthma patients taking medium-/high-dose treatment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.